Disease-State Leukopaks

Disease-State Leukopaks
Categories: ,

Disease-State Leukopaks provide larger-scale leukapheresis starting material from selected donor populations for cell isolation, immune profiling, therapeutic development, and advanced cellular research.

Because disease-state leukapheresis collections can require highly specific donor and project criteria, availability and sourcing feasibility should be discussed directly with CGT Global.

  • Large-volume leukapheresis starting material
  • Suitable for downstream PBMC and immune cell isolation
  • Selected disease-state donor profiles may be evaluated
  • Project-specific donor criteria can be discussed
  • Custom cell isolation may be available
  • Fresh or cryopreserved options depend on collection and project requirements
Add to quote

The CGT Global Difference 

Learn More

Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies.  By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.

CGT Global - Landing Page Desktop Prototype

Description

CGT Global provides disease-state leukopaks from characterized donors for immunology, cell therapy, drug development, assay development, and translational research.

Leukopaks provide a concentrated starting material for PBMC isolation, immune cell enrichment, functional testing, and other applications requiring large numbers of peripheral blood cells. Fresh and cryopreserved formats may be available depending on the disease indication and study requirements.

Key features:

• Fresh or cryopreserved disease-state leukopaks
• Characterized and recallable donors
• High-volume cellular starting material
• Donor demographic and clinical information when available
• Custom donor eligibility criteria
• Coordinated collection, processing, and shipping
• Prospective collection programs available

Disease-state donor and leukopak availability varies significantly by diagnosis. Contact our team to discuss feasibility, timelines, and collection specifications.

For research use only. Not for diagnostic or therapeutic use.

Related products